Impax Laboratories, Inc. (IPXL:NASDAQ) – market cap as of 27/10/2017: $1.40bn Introduction On October 17, 2017, Amneal Pharmaceuticals and Impax Laboratories announced that they will merge in an all-stock transaction. Amneal will hold c. 75% of the combined entity, whereas Impax shareholders will own the remaining stake (c. 25%). These Read more…
Swift Transportation Co (SWFT:NYQ) – market cap as of 29/04/2017: $3.27bn Knight Transportation Inc. (KNX:NYQ) – market cap as of 29/04/2017: $2.76bn Introduction On April 10, 2017, Swift and Knight have agreed to merge in an all-stock transaction that is expected to create the largest player in the Transportation and Read more…
Standard Life plc (SL.: LSE) – market cap as of 10/03/2017: £7.52bn Aberdeen Asset Management PLC (ADN: LSE) — market cap as of 10/03/2017: £3.77bn Introduction On March 6, 2017, it was announced that Standard Life plc (“Standard Life”) has agreed to acquire Aberdeen Asset Management PLC (“Aberdeen”) in an Read more…